BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22791819)

  • 21. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
    Rachagani S; Senapati S; Chakraborty S; Ponnusamy MP; Kumar S; Smith LM; Jain M; Batra SK
    Br J Cancer; 2011 Mar; 104(6):1038-48. PubMed ID: 21364589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.
    Srivastava SK; Bhardwaj A; Singh S; Arora S; Wang B; Grizzle WE; Singh AP
    Carcinogenesis; 2011 Dec; 32(12):1832-9. PubMed ID: 21983127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
    Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH
    Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion.
    Xie CG; Wei SM; Chen JM; Xu XF; Cai JT; Chen QY; Jia LT
    PLoS One; 2012; 7(5):e37854. PubMed ID: 22662237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
    Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
    Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.
    Senapati S; Chaturvedi P; Chaney WG; Chakraborty S; Gnanapragassam VS; Sasson AR; Batra SK
    Clin Cancer Res; 2011 Jan; 17(2):267-74. PubMed ID: 21059814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.
    Nishioka R; Itoh S; Gui T; Gai Z; Oikawa K; Kawai M; Tani M; Yamaue H; Muragaki Y
    Exp Mol Pathol; 2010 Oct; 89(2):149-57. PubMed ID: 20576520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
    Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
    Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4.
    Xie K; Zhi X; Tang J; Zhu Y; Zhang J; Li Z; Tao J; Xu Z
    Oncol Rep; 2014 May; 31(5):2187-94. PubMed ID: 24676527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
    Singh AP; Moniaux N; Chauhan SC; Meza JL; Batra SK
    Cancer Res; 2004 Jan; 64(2):622-30. PubMed ID: 14744777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.
    Xu D; Liu S; Zhang L; Song L
    Biochem Biophys Res Commun; 2017 Apr; 485(2):556-562. PubMed ID: 27923652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
    Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Yan ML; Huang L; Tian YF; Chen YL; Wang YD
    Cancer Lett; 2016 Dec; 383(1):73-84. PubMed ID: 27693633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway.
    Zhang Y; Zhou M; Wei H; Zhou H; He J; Lu Y; Wang D; Chen B; Zeng J; Peng W; Du F; Gong A; Xu M
    Int J Oncol; 2017 Apr; 50(4):1352-1362. PubMed ID: 28259973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival.
    Joshi S; Kumar S; Ponnusamy MP; Batra SK
    Oncogene; 2016 Nov; 35(45):5882-5892. PubMed ID: 27109098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells.
    Moniaux N; Chaturvedi P; Varshney GC; Meza JL; Rodriguez-Sierra JF; Aubert JP; Batra SK
    Br J Cancer; 2007 Aug; 97(3):345-57. PubMed ID: 17595659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways.
    Jonckheere N; Skrypek N; Merlin J; Dessein AF; Dumont P; Leteurtre E; Harris A; Desseyn JL; Susini C; Frénois F; Van Seuningen I
    PLoS One; 2012; 7(2):e32232. PubMed ID: 22393391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.